Sign in

What researchers published on Sjögren's disease

7,145 papers, newest first.

Showing 20 of 132

  • Randomised trialIanalumab for the Treatment of Patients with Sjögren's Disease.The New England journal of medicine
  • Trial result68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.Rheumatology (Oxford, England)
  • Randomised trialRepurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial.The Lancet. Rheumatology
  • Randomised trialInflammatory cytokines, autoantibodies and salivary gland function in Sjögren's syndrome: Effects of T. wilfordii as Hook F medical wine and tripterygium glycosides tablets.International journal of clinical pharmacology and therapeutics
  • Randomised trialLaser Acupuncture on the Management of Xerostomia in Sjögren's Disease: A Randomized Clinical Trial.Oral diseases
  • Randomised trialEfgartigimod in Sjögren's disease: a phase 2, randomised, placebo-controlled, parallel-group, double-blinded, proof-of-concept study (RHO).Annals of the rheumatic diseases
  • Randomised trialEffectiveness of a Biopsychosocial-Based Exercise Approach Delivered in Group and Individual Formats in Primary Sjögren Disease: A Randomized Controlled Trial.Archives of physical medicine and rehabilitation
  • Randomised trialLower magnitude of humoral response to recombinant herpes zoster vaccine in immunocompromised Sjögren's disease patients: evidence from a randomized double-blinded placebo-controlled trial.Seminars in arthritis and rheumatism
  • Trial resultEnhanced efficacy of 0.05% cyclosporine a combined with absorbable punctal plugs in Sjögren's syndrome-associated dry eye: a paired-eye clinical trial.Frontiers in medicine
  • Randomised trialEfficacy and safety of iguratimod in patients with primary Sjögren's syndrome: a multicentre randomised controlled trial.RMD open
  • Trial resultEvaluation of umbilical cord blood serum eye drops for severe dry eye in two distinct populations-Sjögren's syndrome and mustard gas-induced ocular injury: Protocol for a pilot randomized clinical trial.PloS one
  • Randomised trialEfficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial.Lancet (London, England)
  • Randomised trialProteins linked to type II interferon response in Sjögren's disease: novel indicators for disease monitoring and predicting treatment response to leflunomide and hydroxychloroquine combination therapy.Frontiers in immunology
  • Randomised trialEfficacy of topical mesenchymal stem cell exosome in Sjögren's syndrome-related dry eye: a randomized clinical trial.BMC ophthalmology
  • Trial resultA first-in-human, prospective pilot trial of umbilical cord-derived mesenchymal stem cell eye drops therapy for patients with refractory non-Sjögren's and Sjögren's syndrome dry eye disease.Stem cell research & therapy
  • Randomised trialProspective Sham-Controlled trial: acupuncture for symptom-relieving in patients with Sjögren's disease.Clinical rheumatology
  • Trial resultVarenicline Solution Nasal Spray for the Treatment of Dry Eye Disease in Sjogren's Disease: A Pilot Study.Clinical ophthalmology (Auckland, N.Z.)
  • Trial resultEvaluating the therapeutic potential of tofacitinib in Sjögren's disease: a comprehensive clinical and immunological assessment.Rheumatology (Oxford, England)
  • Randomised trialThe Effect of Autologous Serum Tears 50% on the Ocular Surface of Patients With Severe Dry Eye Disease due to Sjogren Syndrome: A Prospective, Double-Blind, Randomized, Controlled, Contralateral Eye Study.Cornea
  • Randomised trialAbatacept use for 24 weeks has a limited effect on salivary gland inflammation in Sjögren's disease patients.Clinical and experimental rheumatology